ASH is Continuing Its Advocacy to Protect Vulnerable Children
American Society of Hematology (ASH) shared a post on LinkedIn:
“The American Society of Hematology is continuing its advocacy to protect vulnerable children. After submitting comments to the CDC’s Advisory Committee on Immunization Practices (ACIP) in September, ASH has reinforced its message ahead of the December meeting:
➡ Maintain the current child and adolescent immunization schedule.
➡ Preserve Hepatitis B vaccine protocols.
Children with hematologic conditions—such as sickle cell disease, leukemia, hemophilia, and other blood disorders—are immunocompromised and face heightened risks from infections that vaccines can prevent. Vaccines are not just preventive; they are lifesaving.

Read the full comment”
Get the latest from Hemostasis Today.
-
Nov 13, 2026, 16:17Shailendra Singh: Bombay Hospital Jaipur Inaugurates New Facility with Voluntary Blood Donation Camp
-
Nov 13, 2026, 16:10Minka Zivkovic: UMC Utrecht Announces Research Analyst Vacancy in Thrombosis and Haemostasis
-
Nov 13, 2026, 16:02Rounak Dubey: Elsevier’s Upcoming Handbook Explores Digitalization in Transfusion Medicine
-
Nov 13, 2026, 15:50Maha Othman: CanVECTOR 2026 Highlights Research on Immunothrombosis and Cancer-Associated Thrombosis
-
Nov 13, 2026, 15:48Cedric Hermans: Advances in Gene Therapy for Haemophilia A
-
Nov 13, 2026, 15:45Strengthens Global Collaboration in Thrombosis and Hemostasis for 2027 – ISTH
-
Nov 13, 2026, 15:42David McIntosh: The Global Blood Shortage Crisis and the Urgent Need for National Action
-
Nov 13, 2026, 15:41JTH Highlights Future Directions in Thromboprophylaxis for Hospitalized Children
-
Nov 13, 2026, 15:21Wolfgang Miesbach։ Gene Therapy for Haemophilia B Is Cheaper Than Lifelong Factor IX Prophylaxis in Sweden